Evidence map›Paper›PMID 31673428›Full record

ReviewESMO open2019

Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion.

John K Field, Harry deKoning, Mattijs Oudkerk, Sadia Anwar, James Mulshine, Ugo Pastorino, Wilfried Eberhardt, Helmut Prosch

Abstract readReview
In one paragraph

Review in ESMO open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024
    Review
  8. Review
  9. National lung cancer screening program feasibility study in Estonia.Interdisciplinary cardiovascular and thoracic surgery · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography.RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin · 2022
    Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Ongoing challenges in implementation of lung cancer screening.Translational lung cancer research · 2021
    Review
  20. The radiologist's role in lung cancer screening.Translational lung cancer research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

John K FieldDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Harry deKoningDepartment of Public Health, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands.
Mattijs OudkerkCenter for Medical Imaging, University Medical Center Groningen, Groningen, The Netherlands.
Sadia AnwarRespiratory Medicine, University of Nottingham, Nottingham, UK.
James MulshineRush University, Chicago, Illinois, USA.
Ugo PastorinoDepartmnet of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy.
Wilfried EberhardtDepartment of Thoracic Oncology, University of Duisburg-Essen, Duisburg, Germany.
Helmut ProschDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Wien, Austria.

Funding

Department of Health 09/61/01
6 · The paper itself

Abstract

Recent randomised trials on screening with low-dose CT have shown important reductions in lung cancer (LC) mortality and have triggered international efforts to implement LC screening. Detection rates of stage I LC with volume CT approaching 70% have been demonstrated. In April 2019 'ESMO Open - Cancer Horizons' convened a roundtable discussion on the challenges and potential solutions regarding the implementation of LC screening in Europe. The expert panel reviewed the current evidence for LC screening with low-dose CT and discussed the next steps, which are covered in this article. The panel concluded that national health policy groups in Europe should start to implement CT screening as adequate evidence is available. It was recognised that there are opportunities to improve the screening process through 'Implementation Research Programmes'.

Indexed as

lung cancer mortalityLung cancer screeningnodule managementpatient recruitmentsecondary care pathways

Identifiers

PMID31673428
PMCPMC6802961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.